CD1D and neoplasm: The high conservation between human and mouse CD1d, and CD1d-restricted NKT cells, and their strong cytokine mediated immunomodulatory effects, has prompted studies investigating NKT cell directed therapy in various immune settings ranging from autoimmunity to tumor immunity.